ArticleNeurology international2025

Identifying Factors Associated with the Efficacy of Lasmiditan 50 mg as an Acute Treatment for Migraine Attacks Under Various Dosing Conditions in Real-World Clinical Practice.

Takafumi Tanei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.